M Vanrumbeke

1.2k total citations
18 papers, 957 citations indexed

About

M Vanrumbeke is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Vanrumbeke has authored 18 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Vanrumbeke's work include Acute Myeloid Leukemia Research (4 papers), Cancer-related Molecular Pathways (4 papers) and Virus-based gene therapy research (2 papers). M Vanrumbeke is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer-related Molecular Pathways (4 papers) and Virus-based gene therapy research (2 papers). M Vanrumbeke collaborates with scholars based in France and United States. M Vanrumbeke's co-authors include Claude Preudhomme, Pierre Fenaux, Eric Wattel, F Bauters, Pascale Lepelley, Bruno Quesnel, JL Laï, I. Quiquandon, Marc Zandecki and M Flactif and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

M Vanrumbeke

18 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Vanrumbeke France 13 444 438 395 276 187 18 957
HG Ahuja United States 12 458 1.0× 538 1.2× 409 1.0× 313 1.1× 144 0.8× 22 1.1k
Michael Neat United Kingdom 18 259 0.6× 557 1.3× 493 1.2× 166 0.6× 298 1.6× 38 1.1k
Barbara Crescenzi Italy 18 207 0.5× 476 1.1× 344 0.9× 235 0.9× 161 0.9× 55 1.0k
Tim Svenstrup Poulsen Denmark 17 323 0.7× 173 0.4× 324 0.8× 194 0.7× 309 1.7× 71 896
Sylvie Ramond France 13 274 0.6× 402 0.9× 312 0.8× 287 1.0× 145 0.8× 18 792
Nicola Foot United Kingdom 14 200 0.5× 481 1.1× 402 1.0× 213 0.8× 157 0.8× 25 837
I. Quiquandon France 12 276 0.6× 459 1.0× 226 0.6× 210 0.8× 193 1.0× 17 774
James Dalton United States 8 210 0.5× 497 1.1× 550 1.4× 188 0.7× 228 1.2× 14 1.3k
Ming-Sheng Lee United States 8 445 1.0× 308 0.7× 209 0.5× 328 1.2× 517 2.8× 10 1.0k
JM Trujillo United States 17 198 0.4× 986 2.3× 480 1.2× 397 1.4× 100 0.5× 35 1.4k

Countries citing papers authored by M Vanrumbeke

Since Specialization
Citations

This map shows the geographic impact of M Vanrumbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Vanrumbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Vanrumbeke more than expected).

Fields of papers citing papers by M Vanrumbeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Vanrumbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Vanrumbeke. The network helps show where M Vanrumbeke may publish in the future.

Co-authorship network of co-authors of M Vanrumbeke

This figure shows the co-authorship network connecting the top 25 collaborators of M Vanrumbeke. A scholar is included among the top collaborators of M Vanrumbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Vanrumbeke. M Vanrumbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
González, Ricardo, Rodolphe Vereecque, Thomas J. Wickham, et al.. (1999). Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Therapy. 6(3). 314–320. 46 indexed citations
2.
Preudhomme, Claude, M Vanrumbeke, Laurence Detourmignies, et al.. (1998). Very low incidence of p53 antibodies in adult non‐Hodgkin's lymphoma and multiple myeloma. British Journal of Haematology. 100(1). 184–186. 3 indexed citations
3.
Preudhomme, Claude, Catherine Nisse, Mohamed Hebbar, et al.. (1997). Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia. 11(9). 1580–1582. 40 indexed citations
4.
Preudhomme, Claude, Bruno Cazin, JL Laï, et al.. (1997). Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL). Leukemia. 11(2). 294–298. 60 indexed citations
5.
Preudhomme, Claude, Catherine Nisse, Mohamed Hebbar, et al.. (1997). 11 Glutathione S transferase theta 1 (GSTT1) gene defects in myelodysplastic syndromes (MDS) and their correlation with Kryotype and exposure to potential carcinogens. Leukemia Research. 21(1). S3–S3. 2 indexed citations
6.
Wattel, Eric, M Vanrumbeke, Nathalie Cambier, et al.. (1996). Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.. PubMed. 10(1). 171–4. 47 indexed citations
7.
Preudhomme, Claude, Isabelle Dervite, Eric Wattel, et al.. (1995). Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.. Journal of Clinical Oncology. 13(4). 812–820. 67 indexed citations
8.
Quesnel, Bruno, Claude Preudhomme, N Philippe, et al.. (1995). p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood. 85(3). 657–663. 117 indexed citations
9.
Laï, JL, Claude Preudhomme, Marc Zandecki, et al.. (1995). Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.. PubMed. 9(3). 370–81. 141 indexed citations
10.
Preudhomme, Claude, Marc Zandecki, M Vanrumbeke, et al.. (1994). MDS and AML with 17p deletion are associated to specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia Research. 18. 9–9. 6 indexed citations
11.
Quesnel, Bruno, Claude Preudhomme, M Vanrumbeke, et al.. (1994). Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.. PubMed. 8(5). 878–80. 12 indexed citations
12.
Preudhomme, Claude, Richard Lubin, Pascale Lepelley, M Vanrumbeke, & Pierre Fenaux. (1994). Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.. PubMed. 8(9). 1589–91. 21 indexed citations
13.
Wattel, Eric, Claude Preudhomme, B Hecquet, M Vanrumbeke, & Pierre Fenaux. (1994). P53 mutations are a strong prognostic factor of response to chemotherapy and survival in myelodysplastic syndromes (MDS). Leukemia Research. 18. 49–49. 1 indexed citations
14.
Lepelley, Pascale, Claude Preudhomme, M Vanrumbeke, et al.. (1994). Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.. PubMed. 8(8). 1342–9. 68 indexed citations
15.
Fenaux, Pierre, Claude Preudhomme, JL Laï, et al.. (1992). Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.. PubMed. 6(4). 246–50. 122 indexed citations
16.
Fenaux, Pierre, Claude Preudhomme, I. Quiquandon, et al.. (1992). Mutations of the P53 gene in acute myeloid leukaemia. British Journal of Haematology. 80(2). 178–183. 93 indexed citations
17.
Preudhomme, Claude, Thierry Façon, Marc Zandecki, et al.. (1992). Rare occurrence of P53 gene mutations in multiple myeloma. British Journal of Haematology. 81(3). 440–443. 62 indexed citations
18.
Fenaux, Pierre, P Jonveaux, I. Quiquandon, et al.. (1992). Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.. PubMed. 6(1). 42–6. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026